Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
158.3 USD | -0.85% | -3.71% | +2.12% |
May. 22 | Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug | MT |
May. 17 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.12% | 282B | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B | |
+6.42% | 166B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine